brl 42810 has been researched along with Cytomegalovirus Retinitis in 3 studies
Cytomegalovirus Retinitis: Infection of the retina by cytomegalovirus characterized by retinal necrosis, hemorrhage, vessel sheathing, and retinal edema. Cytomegalovirus retinitis is a major opportunistic infection in AIDS patients and can cause blindness.
Excerpt | Relevance | Reference |
---|---|---|
"To explore the possibility of oral antiviral therapy in lieu of intravenous acyclovir for treating acute retinal necrosis (ARN), a necrotizing retinopathy caused by herpes simplex virus type 1 or 2 or by varicella zoster virus." | 3.73 | Primary treatment of acute retinal necrosis with oral antiviral therapy. ( Emerson, GG; Flaxel, CJ; Rosenbaum, JT; Smith, JR; Wilson, DJ, 2006) |
" Thalidomide (Synovir), developed by Celgene, has received limited approval for the treatment of leprosy." | 3.70 | FDA approves fomivirsen, famciclovir, and Thalidomide. Food and Drug Administration. ( Highleyman, L, 1998) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Wong, RW | 1 |
Jumper, JM | 1 |
McDonald, HR | 1 |
Johnson, RN | 1 |
Fu, A | 1 |
Lujan, BJ | 1 |
Cunningham, ET | 1 |
Emerson, GG | 1 |
Smith, JR | 1 |
Wilson, DJ | 1 |
Rosenbaum, JT | 1 |
Flaxel, CJ | 1 |
Highleyman, L | 1 |
1 review available for brl 42810 and Cytomegalovirus Retinitis
Article | Year |
---|---|
Emerging concepts in the management of acute retinal necrosis.
Topics: 2-Aminopurine; Acyclovir; Antiviral Agents; Cytomegalovirus Retinitis; Eye Infections, Viral; Famcic | 2013 |
2 other studies available for brl 42810 and Cytomegalovirus Retinitis
Article | Year |
---|---|
Primary treatment of acute retinal necrosis with oral antiviral therapy.
Topics: 2-Aminopurine; Acyclovir; Administration, Oral; Adult; Aged; Antiviral Agents; Cytomegalovirus Retin | 2006 |
FDA approves fomivirsen, famciclovir, and Thalidomide. Food and Drug Administration.
Topics: 2-Aminopurine; AIDS-Related Opportunistic Infections; Antiviral Agents; Cytomegalovirus Retinitis; D | 1998 |